Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Haifer · SciRah

Researcher profile · Semantic Scholar

C. Haifer

Share profile

C. Haifer — researcher profile on SciRah

h-index: 11
Works: 51
Citations: 667

Most-cited papers

Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial.
C. Haifer, S. Paramsothy, N. Kaakoush, A. Saikal +5 more
2021The Lancet Gastroenterology and Hepatology235 citations
Semantic Scholar
Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice
C. Haifer, C. Kelly, S. Paramsothy, D. Andresen +17 more
2020Gut89 citations
Semantic Scholar
Gut microbiota strain richness is species specific and affects engraftment
A. Chen-Liaw, V. Aggarwala, I. Mogno, C. Haifer +23 more
2024Nature64 citations
Semantic Scholar
Microbial determinants of effective donors in faecal microbiota transplantation for UC
C. Haifer, L. Luu, S. Paramsothy, T. Borody +2 more
2022Gut49 citations
Semantic Scholar
Safety of drugs used for the treatment of Crohn’s disease
A. Pudipeddi, V. Kariyawasam, C. Haifer, B. Baraty +2 more
2019Expert Opinion on Drug Safety36 citations
Semantic Scholar
Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection
C. Haifer, S. Paramsothy, T. Borody, Annabel K Clancy +2 more
2021mSystems30 citations Open access
Semantic Scholar
The role of faecal microbiota transplantation in the treatment of inflammatory bowel disease
C. Haifer, Rupert Leong, S. Paramsothy
2020Current opinion in pharmacology (Print)27 citations Open access
Semantic Scholar
Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort study
C. Haifer, A. Srinivasan, Y. An, S. Picardo +5 more
2020Medical Journal of Australia25 citations
Semantic Scholar
Response to faecal microbiota transplantation in ulcerative colitis is not sustained long term following induction therapy
C. Haifer, A. Saikal, R. Paramsothy, N. Kaakoush +4 more
2020Gut23 citations
Semantic Scholar
The phageome of patients with ulcerative colitis treated with donor fecal microbiota reveals markers associated with disease remission
M. Majzoub, S. Paramsothy, C. Haifer, Rohit Parthasarathy +4 more
2024Nature Communications18 citations Open access
Semantic Scholar
Effects of Thiopurine Withdrawal on Vedolizumab-Treated Patients With Ulcerative Colitis: a Randomized Controlled Trial.
A. Pudipeddi, S. Paramsothy, V. Kariyawasam, R. Paramsothy +14 more
2024Clinical Gastroenterology and Hepatology17 citations Open access
Semantic Scholar
A Global Survey of Gastroenterologists’ Travel Advice to Patients with Inflammatory Bowel Disease on Immunosuppressive Agents and Management of Those Visiting Tuberculosis-Endemic Areas
W. Chan, H. Shim, S. Ng, Jeffrey Liu +5 more
2018Journal of Crohn's & Colitis10 citations
Semantic Scholar
Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease
W. Chan, N. Lynch, P. Bampton, Jeff Chang +12 more
2018European Journal of Gastroenterology and Hepathology9 citations
Semantic Scholar
Refining microbial community metabolic models derived from metagenomics using reference-based taxonomic profiling
M. Majzoub, Laurence D W Luu, C. Haifer, S. Paramsothy +4 more
2024mSystems7 citations Open access
Semantic Scholar
Key metabolomic alterations are associated with ulcerative colitis disease state and activity: a validation analysis
J. Chetwood, S. Paramsothy, C. Haifer, T. Borody +3 more
2023Gut5 citations
Semantic Scholar
Bacterial taxonomic and functional changes following oral lyophilized donor fecal microbiota transplantation in patients with ulcerative colitis
S. Raich, M. Majzoub, C. Haifer, S. Paramsothy +4 more
2025mSystems4 citations Open access
Semantic Scholar
Acute severe ulcerative colitis patients from Asia have lower colectomy risk than patients from Australasia.
R. Fernandes, Dong Hyun Kim, L. Ruddick-Collins, A. Vasudevan +39 more
2025Clinical Gastroenterology and Hepatology3 citations
Semantic Scholar
Gut microbiota bacterial strain richness is species specific and limits therapeutic engraftment
A. Chen-Liaw, V. Aggarwala, I. Mogno, C. Haifer +16 more
2022bioRxiv3 citations Open access
Semantic Scholar
Vitamin D metabolites are lower with active Crohn’s disease and spontaneously recover with development of remission
C. Haifer, I. Lawrance, J. Center, Michael Clarke +4 more
2019Therapeutic Advances in Gastroenterology3 citations Open access
Semantic Scholar
Expert-led didactic versus self-directed audiovisual training of confocal laser endomicroscopy in evaluation of mucosal barrier defects
Roy Huynh, Matthew H. Ip, Jeff Chang, C. Haifer +1 more
2018Endoscopy International Open3 citations Open access
Semantic Scholar
Primary sclerosing cholangitis displays distinct colonic mucosa topography yet a shared mast cell state with ulcerative colitis
Jacqueline le Tearle, Ekaterina Sviriaeva, Fan Zhang, Katherine J. L. Jackson +18 more
2026Nature Communications2 citations Open access
Semantic Scholar
Comparing Long‐Term Infliximab Persistence Following a Switch to a Biosimilar in Patients With Inflammatory Bowel Disease: No Cause for Concern
P. Suo, Ashish R. Srinivasan, L. Thin, Yoon K An +9 more
2025Journal of Gastroenterology and Hepatology2 citations Open access
Semantic Scholar
Switching Australian patients with moderate to severe inflammatory bowel disease from originator infliximab to biosimilar Inflectra: Interim results from a multicenter parallel cohort study
C. Haifer, A. Srinivasan, S. Menon, Y. An +5 more
20192 citations
Semantic Scholar
P0754 Extensive disease clearance as a novel composite endpoint to predict long-term relapse in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial
A. Pudipeddi, H. Lin, S. Paramsothy, V. Kariyawasam +15 more
2025Journal of Crohn's & Colitis1 citations
Semantic Scholar
Faecal transplantation: the good, the bad and the ugly
H. Sin, C. Haifer
2024Internal medicine journal (Print)1 citations
Semantic Scholar
P413 Withdrawal versus continuation of thiopurine in vedolizumab-treated patients with Ulcerative Colitis (VIEWS): a multi-centre randomised controlled trial
A. Pudipeddi, S. Paramsothy, V. Kariyawasam, R. Paramsothy +11 more
2023Journal of Crohn's & Colitis1 citations
Semantic Scholar
1029 WITHDRAWAL VERSUS CONTINUATION OF THIOPURINE IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS (VIEWS): A MULTI-CENTRE RANDOMISED CONTROLLED TRIAL
A. Pudipeddi, S. Paramsothy, V. Kariyawasam, R. Paramsothy +13 more
2023Gastroenterology1 citations Open access
Semantic Scholar
IDDF2022-ABS-0162 Histological remission using a nancy index of 0 is associated with longer relapse-free survival than histological activity in patients with ulcerative colitis in clinical and endoscopic remission
A. Pudipeddi, C. Fung, V. Kariyawasam, R. Paramsothy +8 more
2022Clinics in gastroenterology1 citations
Semantic Scholar
680 LYOPHILIZED ORALLY ADMINISTERED FECAL MICROBIOTA TRANSPLANTATION IN THE MANAGEMENT OF ULCERATIVE COLITIS (LOTUS STUDY) – RESULTS FROM THE INDUCTION PHASE OF A RANDOMIZED CONTROLLED TRIAL
C. Haifer, A. Saikal, S. Paramsothy, T. Borody +3 more
20211 citations
Semantic Scholar
Sa1913 CONSENSUS GUIDELINES FOR THE REGULATION, PRODUCTION AND USE OF FECAL MICROBIOTA TRANSPLANTATION IN CLINICAL PRACTICE
C. Haifer, C. Kelly, S. Paramsothy, D. Andresen +17 more
20201 citations
Semantic Scholar
Elevator Pitches
Norman J. Galbraith, K. Ochiai, Jaganmurugan Ramamurthy, Michael G. White +129 more
2025Colorectal Disease0 citations
Semantic Scholar
IBD 2024: Charting a New Course in IBD Proceedings of the Takeda Symposium 22–23 November 2024 W Hotel, Brisbane, Queensland, Australia
U. Mahadevan, V. Jairath, J. Begun, A. Pudipeddi +12 more
2025Journal of Gastroenterology and Hepatology0 citations Open access
Semantic Scholar
Mo2118: INTESTINAL ULTRASOUND IN IMMUNE CHECKPOINT INHIBITORRELATED COLITIS
H. Sin, B. Baraty, Victoria M. Li, S. Ghaly +1 more
2025Gastroenterology0 citations
Semantic Scholar
Author Correction: Gut microbiota strain richness is species specific and affects engraftment
A. Chen-Liaw, V. Aggarwala, I. Mogno, C. Haifer +23 more
2025Nature0 citations Open access
Semantic Scholar
P0227 Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study
S. Kim, D. Kim, S. Park, K. Kim +36 more
2025Journal of Crohn's & Colitis0 citations
Semantic Scholar
Su1899: EXTENSIVE DISEASE CLEARANCE AS A NOVEL COMPOSITE ENDPOINT TO PREDICT LONG-TERM RELAPSE IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS: A POST-HOC ANALYSIS FROM THE VIEWS RANDOMISED CONTROLLED TRIAL
A. Pudipeddi, S. Paramsothy, V. Kariyawasam, R. Paramsothy +14 more
2025Gastroenterology0 citations
Semantic Scholar
Su1943: CORRELATION OF BIOCHEMICAL, ENDOSCOPIC AND HISTOLOGIC ENDPOINTS IN VEDOLIZUMAB-TREATED PATIENTS WITH ULCERATIVE COLITIS: A POST-HOC ANALYSIS FROM THE VIEWS RANDOMISED CONTROLLED TRIAL
A. Pudipeddi, S. Paramsothy, V. Kariyawasam, R. Paramsothy +14 more
2025Gastroenterology0 citations
Semantic Scholar
Low Rates of Surgical Recurrence Following Ileocolic Resections for Crohn's Disease in the Biologic Era.
Hugh L. Giddings, Kheng-Seong Ng, Michael Solomon, Arteen Arzivian +25 more
2025Inflammatory Bowel Diseases0 citations Open access
Semantic Scholar
DOP043 Clinical outcomes and predictive factors differ in acute severe ulcerative colitis for East Asian and Western patients
E. S. Kim, H. S. Lee, D. Kim, H. Kim +36 more
2025Journal of Crohn's & Colitis0 citations
Semantic Scholar
P0257 Correlation of biochemical, endoscopic and histologic endpoints in vedolizumab-treated patients with ulcerative colitis: a post-hoc analysis from the VIEWS randomised controlled trial
A. Pudipeddi, P. Dhanji, S. Paramsothy, V. Kariyawasam +15 more
2025Journal of Crohn's & Colitis0 citations
Semantic Scholar
P753 Comparing long-term outcomes in inflammatory bowel disease patients between switch and non-switch cohorts: no differences in infliximab persistence or safety outcomes after 54 months
P. Suo, L. Thin, A. Srinivasan, J. Winston +4 more
2023Journal of Crohn's & Colitis0 citations Open access
Semantic Scholar
Su1782 QUALITY, SAFETY AND EQUITY OF CARE OUTCOMES FOR INFLAMMATORY BOWEL DISEASE PATIENTS AT FOUR AUSTRALIAN TERTIARY REFERRAL CENTRES USING THE CLOUD-BASED MANAGEMENT SYSTEM CROHN'S COLITIS CARE (CCCARE) : A REAL WORLD OBSERVATIONAL STUDY
M. Cheema, J. Pipicella, I. Narouz, F. Garden +12 more
2023Gastroenterology0 citations
Semantic Scholar
Oral faecal microbiota transplantation in ulcerative colitis - Authors' reply.
C. Haifer, S. Paramsothy, N. Kaakoush, Rupert Leong
2022The Lancet Gastroenterology and Hepatology0 citations
Semantic Scholar
Editorial: outcomes following a second switch—evaluating clinical outcomes and patient perspectives in IBD
A. Srinivasan, C. Haifer, L. Thin
2021Alimentary Pharmacology and Therapeutics0 citations Open access
Semantic Scholar
Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab
A. Srinivasan, C. Haifer, L. Thin
2021Medical Journal of Australia0 citations
Semantic Scholar
Lyophilised Oral Faecal Microbiota Transplantation in Ulcerative Colitis - a Randomised Placebo-Controlled Trial
C. Haifer, Sudarshan Paramosthy, N. Kaakoush, A. Saikal +4 more
2021Social Science Research Network0 citations Open access
Semantic Scholar
OP30 Lyophilised orally administered faecal microbiota transplantation for Active Ulcerative Colitis (LOTUS study)
C. Haifer, A. Saikal, S. Paramsothy, T. Borody +3 more
2021Journal of Crohn's & Colitis0 citations Open access
Semantic Scholar
Catastrophe prevention: Acute severe ulcerative colitis
C. Haifer
2021Journal of Gastroenterology and Hepatology0 citations Open access
Semantic Scholar
Faecal microbiota transplantation as an elixir of youth.
C. Haifer, S. Paramsothy, Rupert Leong
2020Hepatobiliary surgery and nutrition0 citations Open access
Semantic Scholar
Mo1929 ORALLY ADMINISTERED LYOPHILIZED FECAL MICROBIOTA TRANSPLANTATION IN CLOSTRIDIOIDES DIFFICILE INFECTION - LONG TERM CLINICAL AND MICROBIOLOGICAL OUTCOMES
C. Haifer, S. Paramsothy, T. Borody, Annabel K Clancy +3 more
20200 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Paramsothy×28
Invite
S. Paramsothy — researcher profile on SciRah
Rupert Leong×19
Invite
Rupert Leong — researcher profile on SciRah
N. Kaakoush×15
Invite
N. Kaakoush — researcher profile on SciRah
S. Ghaly×14
Invite
S. Ghaly — researcher profile on SciRah

×14

Invite

J. Begun — researcher profile on SciRah

Invite

T. Borody — researcher profile on SciRah

A. Pudipeddi×10

Invite

A. Pudipeddi — researcher profile on SciRah

R. Paramsothy×9

Invite

R. Paramsothy — researcher profile on SciRah

V. Kariyawasam×9

Invite

V. Kariyawasam — researcher profile on SciRah

Invite

M. Kamm — researcher profile on SciRah

Invite

P. De Cruz — researcher profile on SciRah

Invite

T. Borody — researcher profile on SciRah